Can infection-related inflammation affect sleep, energy, and cognition?

Infection-related inflammation is a biologically credible contributor to fatigue, sleepiness, and cognitive symptoms, but it should not be treated as a proven explanation for progressive cognitive decline on the basis of symptoms or antibody testing alone.

Clinical and mechanistic evidence

• Peripheral cytokines can influence the brain through humoral and neural signaling routes, altering neurotransmission and sickness-behavior pathways. Effects on dopamine- and motivation-related circuitry offer a plausible mechanism for reduced energy, while broader inflammatory effects on brain signaling could affect sleep and cognition.
• Persistent fatigue, sleep disturbance, and cognitive symptoms are commonly reported after infections such as COVID-19. However, evidence that ongoing inflammation causes these symptoms remains mixed. In one 710-person cohort, inflammatory markers associated with cognition in unadjusted analyses but were not retained in multivariable LASSO models.
• A cohort with mean age 62 found admission IL-6 and CRP did not consistently predict subsequent fatigue or sleep disturbance. Other post-infectious cohorts report associations between fatigue and monocyte/immune activation, but these observational findings do not establish an independent causal pathway—particularly for a 74-year-old patient.

Serology and progressive cognitive decline

• A positive antibody test indicates immune recognition of an organism, not necessarily active infection, CNS involvement, or causation of an ongoing cognitive syndrome. Antibodies may persist for years or decades after resolved infection; false-positive and cross-reactive results also occur.
• Attribution of cognitive decline to infection requires a compatible syndrome and tempo, exposure history, neurologic findings, and targeted objective evidence. When CNS infection is clinically suspected, this may include CSF studies and pathogen-directed testing, interpreted alongside clinical and imaging findings.

Bottom line

• Persistent immune activation may contribute to sleep, energy, and cognitive symptoms, but serology alone cannot show that an infection is active or responsible for progressive cognitive decline. Progressive symptoms warrant assessment for common neurologic, metabolic, medication-related, psychiatric, and structural causes, with infectious testing guided by the clinical presentation.